振东制药：第三季度净利润同比增长31.34%

Core Viewpoint - Zhendong Pharmaceutical (300158) reported a decline in revenue for Q3 2025, while net profit showed significant growth compared to the previous year [1] Financial Performance - Q3 revenue reached 758 million yuan, a year-on-year decrease of 0.69% [1] - Q3 net profit was 12.43 million yuan, reflecting a year-on-year increase of 31.34% [1] - Revenue for the first three quarters totaled 2.215 billion yuan, down 2.42% year-on-year [1] - Net profit for the first three quarters was 20.36 million yuan, a decline of 49.25% year-on-year [1] - Basic earnings per share stood at 0.0203 yuan [1]